RY 160.91 0.3555% SHOP 116.03 -0.4718% TD 83.98 0.2148% ENB 62.82 1.4699% BN 68.81 1.6396% TRI 251.78 0.6959% CNQ 39.88 2.0732% CP 103.16 1.9771% CNR 137.31 0.483% BMO 129.32 0.4661% BNS 65.69 0.551% CSU 4682.54 -0.7613% CM 81.6 0.1473% MFC 39.65 -0.0252% ATD 71.3 1.3072% NGT 76.22 -1.6643% TRP 68.46 0.9586% SU 47.8 2.006% WCN 273.36 0.3156% L 213.68 0.1594%
Last update at 2025-04-17T20:08:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
UnitedHealth Q1 earnings signal trouble for Medicare Advantage players
Thu 17 Apr 25, 03:54 PMAs UnitedHealth tumbles, one competitor said they are doing fine
Thu 17 Apr 25, 03:42 PM2 S&P 500 Stocks with Exciting Potential and 1 to Think Twice About
Thu 17 Apr 25, 01:02 PMJim Cramer: Humana (HUM) Keeps Rising – A “Totally Independent” Healthcare Stock
Wed 16 Apr 25, 04:52 PM“Really Incredible!” – Jim Cramer Cheers Humana Inc. (HUM)’s Market Moves
Sun 13 Apr 25, 09:42 PMHumana (NYSE:HUM) Launches US$250 Million Fixed-Income Offering
Sat 12 Apr 25, 05:14 PMMacro Headwind-Immune CVS Health Stock Set to Extend 50% YTD Rally
Thu 10 Apr 25, 10:49 AMHealth Insurance Providers Stocks Q4 Teardown: Humana (NYSE:HUM) Vs The Rest
Thu 10 Apr 25, 09:08 AMUnitedHealth vs. Humana: Which Healthcare Stock Should You Buy Now?
Wed 09 Apr 25, 03:10 PMHumana’s Initiatives Deliver Improved Health Outcomes in Communities
Wed 09 Apr 25, 12:00 PM| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 3568.00M | 3354.00M | 4600.00M | 3456.00M | 2063.00M |
| Minority interest | 4.00M | -1.00000M | - | - | - |
| Net income | 2806.00M | 2933.00M | 3367.00M | 2707.00M | 1683.00M |
| Selling general administrative | - | 10121.00M | 10052.00M | 7381.00M | 7525.00M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 80199.00M | 72943.00M | 67103.00M | 57507.00M | 49387.00M |
| Reconciled depreciation | 845.00M | 713.00M | 616.00M | 575.00M | 534.00M |
| Ebit | 3969.00M | 3418.00M | 4674.00M | 3470.00M | 2292.00M |
| Ebitda | 4814.00M | 4131.00M | 5290.00M | 4045.00M | 2826.00M |
| Depreciation and amortization | 845.00M | 713.00M | 616.00M | 575.00M | 534.00M |
| Non operating income net other | 165.00M | 597.00M | -29.00000M | 520.00M | -819.00000M |
| Operating income | 3969.00M | 3418.00M | 4674.00M | 3470.00M | 2292.00M |
| Other operating expenses | 89302.00M | 79710.00M | 72555.00M | 61432.00M | 54849.00M |
| Interest expense | 401.00M | 326.00M | 283.00M | 242.00M | 218.00M |
| Tax provision | 762.00M | 485.00M | 1307.00M | 763.00M | 391.00M |
| Interest income | 401.00M | 326.00M | 283.00M | 242.00M | 218.00M |
| Net interest income | -401.00000M | -326.00000M | -283.00000M | -242.00000M | -218.00000M |
| Extraordinary items | - | - | - | 0.00000M | -39.00000M |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 762.00M | 485.00M | 1307.00M | 763.00M | 391.00M |
| Total revenue | 92870.00M | 83064.00M | 77155.00M | 64888.00M | 56912.00M |
| Total operating expenses | 89070.00M | -79646.00000M | -72481.00000M | -61418.00000M | 53812.00M |
| Cost of revenue | 12671.00M | 10121.00M | 10052.00M | 7381.00M | 7525.00M |
| Total other income expense net | -401.00000M | -64.00000M | -74.00000M | -14.00000M | -229.00000M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | 2802.00M | 2934.00M | 3293.00M | 2693.00M | 2454.00M |
| Net income applicable to common shares | 2806.00M | 2933.00M | 3367.00M | 2707.00M | 1683.00M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 43055.00M | 44343.00M | 34969.00M | 29074.00M | 25413.00M |
| Intangible assets | 1765.00M | 2639.00M | 329.00M | 177.00M | 245.00M |
| Earning assets | - | - | - | - | - |
| Other current assets | 5567.00M | 6493.00M | 5276.00M | 3806.00M | 3564.00M |
| Total liab | 27685.00M | 28240.00M | 21241.00M | 17037.00M | 15252.00M |
| Total stockholder equity | 15311.00M | 16080.00M | 13728.00M | 12037.00M | 10161.00M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 9526.00M | -254.00000M | -318.00000M | -247.00000M | -283.00000M |
| Common stock | 33.00M | 33.00M | 33.00M | 33.00M | 33.00M |
| Capital stock | 33.00M | 33.00M | 33.00M | 33.00M | 33.00M |
| Retained earnings | 25492.00M | 23086.00M | 20517.00M | 17483.00M | 15072.00M |
| Other liab | 1017.00M | 2371.00M | 1787.00M | 809.00M | 800.00M |
| Good will | 9142.00M | 11092.00M | 4447.00M | 3928.00M | 3897.00M |
| Other assets | 43055.00M | -2335.00000M | -5150.00000M | -5332.00000M | -5332.00000M |
| Cash | 5061.00M | 3394.00M | 4673.00M | 4054.00M | 2343.00M |
| Cash and equivalents | 5061.00M | 3394.00M | 4673.00M | 4054.00M | 2343.00M |
| Total current liabilities | 17178.00M | 15074.00M | 13076.00M | 10888.00M | 10013.00M |
| Current deferred revenue | 286.00M | 254.00M | 318.00M | 247.00M | 283.00M |
| Net debt | 6363.00M | 9426.00M | 2307.00M | 1837.00M | 3897.00M |
| Short term debt | 2390.00M | 2279.00M | 920.00M | 924.00M | 1865.00M |
| Short long term debt | 2390.00M | 2279.00M | 920.00M | 924.00M | 1865.00M |
| Short long term debt total | 11424.00M | 12820.00M | 6980.00M | 5891.00M | 6240.00M |
| Other stockholder equity | -8910.00000M | -7081.00000M | -7213.00000M | -5635.00000M | -4785.00000M |
| Property plant equipment | 3221.00M | 3073.00M | 2371.00M | 1955.00M | 1735.00M |
| Total current assets | 26183.00M | 18400.00M | 18365.00M | 16082.00M | 13384.00M |
| Long term investments | 15010.00M | 14113.00M | 2382.00M | 1469.00M | 1458.00M |
| Net tangible assets | 6169.00M | 4988.00M | 9281.00M | 8109.00M | 6264.00M |
| Short term investments | 13881.00M | 13192.00M | 12554.00M | 10972.00M | 10026.00M |
| Net receivables | 1674.00M | 1814.00M | 1138.00M | 1056.00M | 1015.00M |
| Long term debt | 9034.00M | 10541.00M | 6060.00M | 4967.00M | 4375.00M |
| Inventory | - | -6493.00000M | -5276.00000M | -3806.00000M | -3564.00000M |
| Accounts payable | 14502.00M | 12795.00M | 12156.00M | 9964.00M | 8148.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | 59.00M | 23.00M | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -1304.00000M | 42.00M | 391.00M | 156.00M | -159.00000M |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | 33.00M | 33.00M | 33.00M | 33.00M | 33.00M |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | 25492.00M | 23086.00M | 20517.00M | 17483.00M | 15072.00M |
| Treasury stock | - | -10163.00000M | -9918.00000M | -8455.00000M | -7320.00000M |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | -10501.00000M | -28278.00000M | -21754.00000M | -18324.00000M | -17361.00000M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 16872.00M | 28278.00M | 21754.00M | 18324.00M | 17361.00M |
| Capital lease obligations | - | - | - | - | - |
| Long term debt total | 9034.00M | 10541.00M | 6060.00M | 4967.00M | 4375.00M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -1006.00000M | -1053.00000M | -1392.00000M | -542.00000M | -1316.00000M |
| Change to liabilities | 1019.00M | -65.00000M | 2738.00M | 1613.00M | -424.00000M |
| Total cashflows from investing activities | -1006.00000M | -6556.00000M | -3065.00000M | -1278.00000M | -3087.00000M |
| Net borrowings | -1428.00000M | 3764.00M | 1078.00M | -369.00000M | 1165.00M |
| Total cash from financing activities | -1914.00000M | 3015.00M | -1955.00000M | -2295.00000M | -785.00000M |
| Change to operating activities | 556.00M | -211.00000M | 2157.00M | 1731.00M | -908.00000M |
| Net income | 2802.00M | 2934.00M | 3367.00M | 2707.00M | 1683.00M |
| Change in cash | 1667.00M | -1279.00000M | 619.00M | 1711.00M | -1699.00000M |
| Begin period cash flow | 3394.00M | 4673.00M | 4054.00M | 2343.00M | 4042.00M |
| End period cash flow | 5061.00M | 3394.00M | 4673.00M | 4054.00M | 2343.00M |
| Total cash from operating activities | 4587.00M | 2262.00M | 5639.00M | 5284.00M | 2173.00M |
| Issuance of capital stock | - | - | - | - | - |
| Depreciation | 845.00M | 713.00M | 616.00M | 575.00M | 534.00M |
| Other cashflows from investing activities | 114.00M | -5240.00000M | -709.00000M | -542.00000M | -1159.00000M |
| Dividends paid | -392.00000M | -354.00000M | -323.00000M | -291.00000M | 265.00M |
| Change to inventory | - | 280.00M | - | - | - |
| Change to account receivables | -54.00000M | -280.00000M | -85.00000M | -32.00000M | -164.00000M |
| Sale purchase of stock | -2096.00000M | -79.00000M | -1820.00000M | -1070.00000M | -1090.00000M |
| Other cashflows from financing activities | 3574.00M | -337.00000M | -939.00000M | -623.00000M | -640.00000M |
| Change to netincome | 201.00M | -828.00000M | 351.00M | 401.00M | 1052.00M |
| Capital expenditures | 1120.00M | 1316.00M | 964.00M | 736.00M | 612.00M |
| Change receivables | -54.00000M | -280.00000M | -85.00000M | -32.00000M | -200.00000M |
| Cash flows other operating | -226.00000M | -426.00000M | -1348.00000M | 20.00M | -472.00000M |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | 1667.00M | -1279.00000M | 619.00M | 1711.00M | -1699.00000M |
| Change in working capital | 534.00M | -556.00000M | 2143.00M | 1663.00M | -1167.00000M |
| Stock based compensation | 216.00M | 180.00M | 181.00M | 163.00M | 137.00M |
| Other non cash items | 290.00M | -1024.00000M | -863.00000M | 14.00M | 792.00M |
| Free cash flow | 3467.00M | 946.00M | 4675.00M | 4548.00M | 1561.00M |
Sector: Healthcare Industry: Healthcare Plans
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | |
|---|---|---|---|---|---|---|---|---|
| HUM Humana Inc |
-21.13 7.40% | 264.48 | 19.16 | 14.60 | 0.56 | 3.37 | 0.53 | |
| UNH UnitedHealth Group Incorporated |
-130.93 22.38% | 454.11 | 22.57 | 18.38 | 1.33 | 5.65 | 1.38 | 13.97 |
| ELV Elevance Health Inc |
-10.51 2.42% | 424.53 | 18.00 | 12.66 | 0.65 | 2.87 | 0.74 | |
| CVS CVS Health Corp |
-1.26 1.84% | 67.29 | 12.06 | 9.08 | 0.29 | 1.34 | 0.47 | 8.96 |
| CI Cigna Corp |
0.69 0.21% | 330.13 | 30.25 | 10.09 | 0.39 | 2.10 | 0.50 |
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of PBM business. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
Humana Building, Louisville, KY, United States, 40202
| Name | Title | Year Born |
|---|---|---|
| Mr. Bruce Dale Broussard | Pres, CEO & Director | 1962 |
| Ms. Susan Marie Diamond | Chief Financial Officer | 1974 |
| Mr. Timothy S. Huval | Chief Admin. Officer | 1966 |
| Mr. Timothy Alan Wheatley | Segment Pres of Retail | 1968 |
| Dr. William Kevin Fleming Pharm.D., PharmD, RPh | Chief Corp. Affairs Officer & Segment Pres of Pharmacy Solutions | 1968 |
| Mr. John-Paul William Felter | Sr. VP, Chief Accounting Officer, Principal Accounting Officer & Controller | 1983 |
| Mr. Sam M. Deshpande | Chief Information Officer | 1965 |
| Lisa M. Stoner | VP of Investor Relations | NA |
| Mr. Joseph C. Ventura | Chief Legal Officer | 1977 |
| Amy Fry | Sr. VP of Corp. Communications | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
CA
NZ
UK
US
AU
IND
Please wait processing your request...